A61L 2300/256
Antibodies
Official title: Antibodies, e.g. immunoglobulins, vaccines
A61L2300/256 (Antibodies) appears on 194 US grants and 288 published applications in this corpus.
Search patents in A61L- Granted patents
- 194
- Published applications
- 288
- Assignees
- 150
- Inventors
- 554
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 1 |
| 2002 | 2 | 3 |
| 2003 | 1 | 4 |
| 2004 | 3 | 4 |
| 2005 | 0 | 12 |
| 2006 | 1 | 6 |
| 2007 | 6 | 15 |
| 2008 | 3 | 20 |
| 2009 | 8 | 8 |
| 2010 | 7 | 20 |
| 2011 | 6 | 9 |
| 2012 | 9 | 13 |
| 2013 | 10 | 7 |
| 2014 | 7 | 6 |
| 2015 | 9 | 18 |
| 2016 | 11 | 27 |
| 2017 | 19 | 11 |
| 2018 | 7 | 15 |
| 2019 | 9 | 15 |
| 2020 | 13 | 12 |
| 2021 | 10 | 15 |
| 2022 | 4 | 7 |
| 2023 | 6 | 16 |
| 2024 | 8 | 13 |
| 2025 | 9 | 7 |
| 2026 | 4 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tough gel-based drug delivery compositions and methods thereof21 Apr 2026US 12,605,480 B2President and Fellows of Harvard College
- Systems and methods of preparing and delivering oocyst solutions21 Apr 2026US 12,605,482 B2Targan, Inc.
- Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation14 Apr 2026US 12,599,663 B2Valitor, Inc.
- Apoptosis-mimicking structures for inducing tissue regeneration10 Feb 2026US 12,544,393 B2The Regents of the University of Michigan
- Structured gels18 Nov 2025US 12,472,284 B2University of Southampton
- Injectable compositions for treating joint conditions16 Jul 2026US 2026/0199558 A1Ohio State Innovation Foundation
- Situ gelling zwitterionic hydrogel compositions, and methods of use thereof23 Apr 2026US 2026/0109821 A1McMaster University
- Methods of altering bone growth by administration of sost or wise antagonist or agonist5 Mar 2026US 2026/0062470 A1Ossifi-Mab LLC
- Functional wound healing dressings29 Jan 2026US 2026/0026975 A1Ambient Biosciences, Inc.
- Utilization of electrophoretic deposition to coat medical implants with therapeutic agents in a sterile clinical setting28 Aug 2025US 2025/0269091 A1Rush University Medical Center
Most cited
By later US patents
- Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor615US 5,328,470 AThe Regents of the University of Michigan · 1994
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Drug delivery390US 5,674,192 ABoston Scientific Corporation · 1997
- Coated implantable medical device378US 6,774,278 B1Cook Incorporated · 2004
- Drug delivery304US 6,409,716 B1SciMed Life Systems, Inc. · 2002